{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:55:53Z","timestamp":1791168953892,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["13\/692"],"award-info":[{"award-number":["13\/692"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["14\/018"],"award-info":[{"award-number":["14\/018"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006346","name":"Faculty of Medical and Health Sciences, University of Auckland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006346","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jconrel.2014.09.030","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T14:06:04Z","timestamp":1413209164000},"page":"208-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"special_numbering":"C","title":["Implants for drug delivery to the posterior segment of the eye: A focus on stimuli-responsive and tunable release systems"],"prefix":"10.1016","volume":"196","author":[{"given":"M. Naveed","family":"Yasin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Svirskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Seyfoddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva D.","family":"Rupenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.09.030_bb0005","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1039\/C4NJ00864B","article-title":"Bioinspired nanoarchitectonics as emerging drug delivery systems","volume":"38","author":"Ariga","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1872211307666131118141600","article-title":"Recent patents on stimuli responsive hydrogel drug delivery system","volume":"7","author":"Patel","year":"2013","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2014.03.052","article-title":"Hydrogels in a historical perspective: from simple networks to smart materials","volume":"190","author":"Buwalda","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0020","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2011.06.009","article-title":"Photoresponsive hydrogels for biomedical applications","volume":"63","author":"Tomatsu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1039\/C1JM13288A","article-title":"Photoactivated nanomaterials for biomedical release applications","volume":"22","author":"Sortino","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0030","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1586\/17434440.2013.839209","article-title":"Progress in biopolymer-based biomaterials and their application in controlled drug delivery","volume":"10","author":"Neffe","year":"2013","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0040","series-title":"Ocular Drug Delivery Systems","first-page":"383","article-title":"Photoresponsive polymers for ocular drug delivery","author":"Wells","year":"2012"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0045","article-title":"Emerging technologies approach complex eye diseases from new directions","volume":"8\u201322","author":"Boyer","year":"2014","journal-title":"Ocul. Surg. News APAO"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0050","first-page":"47","article-title":"Ocular implants for the blind","volume":"33","author":"Wyatt","year":"1996","journal-title":"IEEE"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/IAE.0b013e3181de5609","article-title":"Inject and extend dosing versus dosing as needed a comparative retrospective study of ranibizumab in exudative age-related macular degeneration","volume":"31","author":"Oubraham","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archopht.1992.01080140041022","article-title":"Treatment of cytomegalovirus retinitis","volume":"110","author":"Jabs","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0070","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant","volume":"337","author":"Musch","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0080","doi-asserted-by":"crossref","first-page":"780634","DOI":"10.1155\/2013\/780634","article-title":"Drug delivery implants in the treatment of vitreous inflammation","volume":"2013","author":"Wang","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0085","first-page":"317","article-title":"Sustained release intraocular drug delivery devices for treatment of uveitis","volume":"6","author":"Haghjou","year":"2011","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0095","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.addr.2012.08.006","article-title":"MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications","volume":"64","author":"Meng","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1056-8719(98)00027-6","article-title":"Therapeutic applications of implantable drug delivery systems","volume":"40","author":"Dash","year":"1998","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","article-title":"A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO study","volume":"148","author":"Lalwani","year":"2009","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0142-9612(94)90261-5","article-title":"Preparation and characterization of a glucose-responsive insulin-releasing polymer device","volume":"15","author":"Shiino","year":"1994","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.addr.2012.09.014","article-title":"Responsive polymeric delivery systems","volume":"64","author":"Kost","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0125","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2014.09.030_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000315158","article-title":"Differentiating intraocular glucocorticoids","volume":"224","author":"Edelman","year":"2010","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/11530970-000000000-00000","article-title":"Biodegradable intraocular therapies for retinal disorders: progress to date","volume":"27","author":"Kuno","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0140","first-page":"54","article-title":"Ocular drug delivery systems for the posterior segment: a review","author":"Kuno","year":"2012","journal-title":"Retina Today"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2006.10.031","article-title":"CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina","volume":"1129","author":"Azadi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/02713680903086018","article-title":"Rescue of photoreceptors by BDNF gene transfer using in vivo electroporation in the RCS rat of retinitis pigmentosa","volume":"34","author":"Zhang","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0160","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10544-009-9313-9","article-title":"A passive MEMS drug delivery pump for treatment of ocular diseases","volume":"11","author":"Lo","year":"2009","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0170","first-page":"60","article-title":"Mini drug pump for ophthalmic use","volume":"107","author":"Saati","year":"2009","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0175","unstructured":"J.R. Coppeta, K.N. Horne, A. Poutiatine, J.T. Santini Jr, J.A. Scholl, N. Shams, G.J. Spooner, C.L. Stevenson, Low-permeability, laser-activated drug delivery device, US Patent 13\/023,370 B1, 09\/02\/2012."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.visres.2009.10.013","article-title":"The capsule drug device: novel approach for drug delivery to the eye","volume":"50","author":"Molokhia","year":"2010","journal-title":"Vis. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0185","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1039\/c1lc20134d","article-title":"On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device","volume":"11","author":"Pirmoradi","year":"2011","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0190","first-page":"10","article-title":"Improving outcomes in ophthalmology via sustained drug delivery","volume":"48","author":"Navratil","year":"2014","journal-title":"ONdrugDelivery"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0195","first-page":"20","article-title":"Zero-order sustained drug delivery to the retina from a nanoporous film device","volume":"48","author":"Bernards","year":"2014","journal-title":"ONdrugDelivery"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(90)32552-6","article-title":"Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome","volume":"97","author":"Gross","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0210","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0161-6420(84)34201-4","article-title":"Ophthalmic involvement in acquired immunodeficiency syndrome","volume":"91","author":"Palestine","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00004397-198902920-00009","article-title":"Infections of the retina in AIDS","volume":"29","author":"Culbertson","year":"1989","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0161-6420(87)33454-2","article-title":"Cytomegalovirus retinitis and response to therapy with ganciclovir","volume":"94","author":"Henderly","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-6420(89)32900-9","article-title":"Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results","volume":"96","author":"Cantrill","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archopht.1992.01080140111037","article-title":"Intravitreal sustained-release ganciclovir","volume":"110","author":"Smith","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0235","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archopht.1992.01080140044023","article-title":"Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device","volume":"110","author":"Sanborn","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0245","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/infdis\/163.6.1348","article-title":"Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS","volume":"163","author":"Jacobson","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0250","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJM199710023371424","article-title":"Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome","volume":"337","author":"Jacobson","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0255","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0161-6420(97)30188-2","article-title":"Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome","volume":"104","author":"Taskintuna","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0260","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archopht.116.2.178","article-title":"Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance","volume":"116","author":"Smith","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/opep.11.2.67.28158","article-title":"2002 global update of available data on visual impairment: a compilation of population-based prevalence studies","volume":"11","author":"Pascolini","year":"2004","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amepre.2013.02.018","article-title":"Age-related eye diseases and visual impairment among U.S. adults","volume":"45","author":"Chou","year":"2013","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.13-12789","article-title":"The prevalence of age-related eye diseases and visual impairment in aging: current estimates","volume":"54","author":"Klein","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0280","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","article-title":"Age-related macular degeneration and blindness due to neovascular maculopathy","volume":"102","author":"Ferris","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0285","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","article-title":"Age-related macular degeneration","volume":"372","author":"Coleman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0290","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40266-014-0176-2","article-title":"Intravitreal aflibercept (Eylea(R)): a review of its use in patients with macular oedema secondary to central retinal vein occlusion","volume":"31","author":"Yang","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.eye.6701438","article-title":"Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study","volume":"19","author":"Jonas","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0305","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/jop.2007.0002","article-title":"Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model","volume":"23","author":"Xu","year":"2007","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/IAE.0b013e3180323de7","article-title":"Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone","volume":"27","author":"Augustin","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0340","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7326\/0003-4819-140-11-200406010-00035","article-title":"The evolving diabetes burden in the United States","volume":"140","author":"Engelgau","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0345","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1034\/j.1600-0420.1999.770211.x","article-title":"Diabetic macular edema: risk factors and concomitants","volume":"77","author":"Lopes de Faria","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajo.2008.07.024","article-title":"Etiology and treatment of macular edema","volume":"147","author":"Johnson","year":"2009","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0355","first-page":"0702","article-title":"Diabetic retinopathy (treatment)","volume":"2011","author":"Mohamed","year":"2011","journal-title":"Clin. Evid. (Online)"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12348-011-0042-x","article-title":"Wandering Ozurdex\u00ae implant","volume":"2","author":"Bansal","year":"2012","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0365","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1517\/14656560903160671","article-title":"The use of intraocular corticosteroids","volume":"10","author":"Kiernan","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(98)00023-X","article-title":"Proliferative vitreoretinopathy: an overview","volume":"43","author":"Pastor","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0375","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archopht.1994.01090150137036","article-title":"Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil","volume":"112","author":"Rubsamen","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.116.1.69","article-title":"An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy","volume":"116","author":"Yang","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0385","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/jop.1994.10.561","article-title":"Effects of an intravitreal daunomycin implant on experimental proliferative vitreoretinopathy: simultaneous pharmacokinetic and pharmacodynamic evaluations","volume":"10","author":"Rahimy","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0390","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/02713689609000766","article-title":"An intravitreal device providing sustained release of cyclosporine and dexamethasone","volume":"15","author":"Enyedi","year":"1996","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/02713689509003758","article-title":"Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy","volume":"14","author":"Hashizoe","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0400","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(98)00061-3","article-title":"Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy","volume":"55","author":"Zhou","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0405","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2003.039917","article-title":"An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy","volume":"88","author":"Cardillo","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0410","first-page":"2318","article-title":"Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy","volume":"37","author":"Berger","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0415","first-page":"1325","article-title":"Proliferative vitreoretinopathy: current and emerging treatments","volume":"6","author":"Sadaka","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0420","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch-Michel","year":"1987","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0425","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1167\/iovs.11-8259","article-title":"Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial","volume":"53","author":"Frick","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0430","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2010.05.008","article-title":"Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis","volume":"40","author":"Pato","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0435","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ophtha.2013.08.029","article-title":"The future of uveitis treatment","volume":"121","author":"Lin","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0440","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/1097-4636(20000915)51:4<635::AID-JBM11>3.0.CO;2-O","article-title":"Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate","volume":"51","author":"Kunou","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0445","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0450","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1350-9462(99)00016-6","article-title":"Structural macromolecules and supramolecular organisation of the vitreous gel","volume":"19","author":"Bishop","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0455","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","article-title":"Intraocular implants for extended drug delivery: therapeutic applications","volume":"58","author":"Bourges","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0460","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/jps.21987","article-title":"A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases","volume":"99","author":"Choonara","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14712598.3.1.45","article-title":"Drug delivery to the retina: challenges and opportunities","volume":"3","author":"Duvvuri","year":"2003","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0470","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0039-6257(91)90108-R","article-title":"Scleral implants: an historical perspective","volume":"35","author":"Schepens","year":"1991","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0475","unstructured":"E. de Juan Jr, Y. Alster, K.C. Farinas, K.A. Macfarlane, C.J. Reich, R.E. Campbell, Implantable therapeutic device, US Patent 13\/204,638, 19\/04\/2012."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0480","unstructured":"E. de Juan Jr, Y. Alster, K.C. Farinas, K.A. Macfarlane, C.J. Reich, R.E. Campbell, Implantable therapeutic device, US Patent 13\/204,638, 07\/01\/2014."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0485","first-page":"247","article-title":"Ocular pharmacokinetics of dacarbazine following subconjunctival versus intravenous administration in the rabbit","volume":"26","author":"Kalsi","year":"1991","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0490","doi-asserted-by":"crossref","first-page":"e22507","DOI":"10.1371\/journal.pone.0022507","article-title":"Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes","volume":"6","author":"Peng","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0495","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.actbio.2013.11.004","article-title":"A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye","volume":"10","author":"Nagai","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0500","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","article-title":"Polymers for drug delivery systems","volume":"1","author":"Liechty","year":"2010","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0505","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/2211068211428189","article-title":"Reservoir-based polymer drug delivery systems","volume":"17","author":"Yang","year":"2012","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0510","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1590\/S1984-82502010000300024","article-title":"Implants as drug delivery devices for the treatment of eye diseases","volume":"46","author":"da Silva","year":"2010","journal-title":"Braz. J. Pharm. Sci"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0515","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10611869409015909","article-title":"Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations","volume":"2","author":"Rahimy","year":"1994","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0525","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial","volume":"112","author":"Martin","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0530","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9394(98)00443-7","article-title":"Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis","volume":"127","author":"Lim","year":"1999","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0535","first-page":"3569","article-title":"Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device","volume":"41","author":"Jaffe","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0540","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1345\/aph.1H540","article-title":"Retisert: is the new advance in treatment of uveitis a good one?","volume":"41","author":"Mohammad","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0545","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/ten.2004.10.1617","article-title":"Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device","volume":"10","author":"Thanos","year":"2004","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0550","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2013.03.021","article-title":"Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa","volume":"156","author":"Birch","year":"2013","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0555","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17425247.5.9.1039","article-title":"Iluvien: a new sustained delivery technology for posterior eye disease","volume":"5","author":"Kane","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0560","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2011.02.048","article-title":"Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial","volume":"118","author":"Pearson","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0565","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.addr.2012.02.005","article-title":"Reservoir-based drug delivery systems utilizing microtechnology","volume":"64","author":"Stevenson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0570","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10717540590921432","article-title":"Manufacturing techniques of biodegradable implants intended for intraocular application","volume":"12","author":"Fialho","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0575","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0079-6700(97)00039-7","article-title":"Biodegradable polymers","volume":"23","author":"Chandra","year":"1998","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0580","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.preteyeres.2014.04.002","article-title":"The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies","volume":"42","author":"Herrero-Vanrell","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0585","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.addr.2005.09.005","article-title":"Intraocular sustained drug delivery using implantable polymeric devices","volume":"57","author":"Yasukawa","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0590","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00417-005-0109-1","article-title":"Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis","volume":"244","author":"Dong","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0595","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/02713680500320752","article-title":"FK506 in a biodegradable glycolide-co-clatide-co-caprolactone polymer for prolongation of corneal allograft survival","volume":"30","author":"Shi","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0600","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M","article-title":"A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application","volume":"50","author":"Einmahl","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0605","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/jbm.820190806","article-title":"Bioerodible polyanhydrides as drug-carrier matrices. I: characterization, degradation, and release characteristics","volume":"19","author":"Leong","year":"1985","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0610","first-page":"84","article-title":"Ocular drug delivery via micro and nanoparticles","author":"Rourke","year":"2014","journal-title":"Retina Today"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0615","first-page":"8","article-title":"GrayBug","volume":"48","author":"Rourke","year":"2014","journal-title":"ONdrugDelivery"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0625","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0630","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00417-011-1802-x","article-title":"Anterior chamber migration of dexametasone intravitreal implant (Ozurdex\u00ae)","volume":"250","author":"Pardo-Lopez","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0635","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jpm3010040","article-title":"Personalized medicine in ophthalmology: from pharmacogenetic biomarkers to therapeutic and dosage optimization","volume":"3","author":"Ong","year":"2013","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0640","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.drudis.2007.12.005","article-title":"Ophthalmic light sensitive nanocarrier systems","volume":"13","author":"Christie","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0645","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/ma060142z","article-title":"Toward photocontrolled release using light-dissociable block copolymer micelles","volume":"39","author":"Jiang","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0650","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1039\/b203459j","article-title":"Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo","volume":"1","author":"Juzenas","year":"2002","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0655","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/ma00207a046","article-title":"Photoinduced phase-transition of gels","volume":"23","author":"Mamada","year":"1990","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0660","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1021\/ja0521019","article-title":"A new design for light-breakable polymer micelles","volume":"127","author":"Jiang","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0665","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2007.03.023","article-title":"Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery","volume":"120","author":"Rijcken","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0670","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1039\/c1sm05291h","article-title":"Dextran based photodegradable hydrogels formed via a Michael addition","volume":"7","author":"Peng","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0675","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1073\/pnas.2232479100","article-title":"Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance","volume":"100","author":"Hirsch","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0680","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/1521-3773(20010716)40:14<2581::AID-ANIE2581>3.0.CO;2-2","article-title":"\u201cSynthetic metals\u201d: a novel role for organic polymers (Nobel lecture)","volume":"40","author":"MacDiarmid","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0685","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.aca.2005.10.011","article-title":"Biosensing and drug delivery by polypyrrole","volume":"568","author":"Geetha","year":"2006","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0690","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/elan.200900401","article-title":"Development of a controlled release system for risperidone using polypyrrole: mechanistic studies","volume":"22","author":"Svirskis","year":"2010","journal-title":"Electroanalysis"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0695","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.snb.2010.09.042","article-title":"Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system","volume":"151","author":"Svirskis","year":"2010","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0700","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4155\/tde.12.166","article-title":"Electrically switchable polypyrrole film for the tunable release of progesterone","volume":"4","author":"Svirskis","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0705","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jconrel.2010.03.023","article-title":"Electrochemically controlled drug delivery based on intrinsically conducting polymers","volume":"146","author":"Svirskis","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0710","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E","article-title":"Synthesis of a novel, biodegradable electrically conducting polymer for biomedical applications","volume":"12","author":"Rivers","year":"2002","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0715","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2013.01.006","article-title":"High surface area polypyrrole scaffolds for tunable drug delivery","volume":"443","author":"Sharma","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0720","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.electacta.2009.08.049","article-title":"A polypyrrole-based microchip for controlled drug release","volume":"55","author":"Ge","year":"2009","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0725","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.snb.2011.11.085","article-title":"Multiplexed and switchable release of distinct fluids from microneedle platforms via conducting polymer nanoactuators for potential drug delivery","volume":"161","author":"Valdes-Ramirez","year":"2012","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0730","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2005.10.027","article-title":"Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode","volume":"110","author":"Wadhwa","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0735","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/27\/275102","article-title":"A mesoporous silica nanosphere-based drug delivery system using an electrically conducting polymer","volume":"20","author":"Cho","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0740","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/marc.200400463","article-title":"Synthesis of large-area three-dimensional polyaniline nanowire networks using a \u201csoft template\u201d","volume":"26","author":"Zhong","year":"2005","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0745","unstructured":"M.B. Cannell, R.P. Cooney, P. Kilmartin, C. Soeller, J. Travas-Sejdic, Microfabricated device, US Patent 11\/989,984, 11\/03\/2010."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0750","unstructured":"K.L. Morgan, A.M. Shelchuk, J.D. Snell, N. Holmstr\u00f6m, J.R. Helland, Electroactive polymer-actuated peristaltic pump and medical lead incorporating such a pump, US Patent 11\/404,268, 08\/07\/2008."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0755","series-title":"Smart Materials for Drug Delivery","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1039\/9781849736800-00283","article-title":"Advances in drug-delivery systems based on intrinsically conducting polymers","author":"Sharma","year":"2013"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0760","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/polym3010150","article-title":"A polyvinyl alcohol-polyaniline based electro-conductive hydrogel for controlled stimuli-actuable release of indomethacin","volume":"3","author":"Tsai","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0765","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003276","article-title":"First-in-human testing of a wirelessly controlled drug delivery microchip","volume":"4","author":"Farra","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0770","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.synthmet.2005.07.008","article-title":"The development and characterisation of conducting polymeric-based sensing devices","volume":"154","author":"Brady","year":"2005","journal-title":"Synth. Met."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0775","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.sna.2004.10.020","article-title":"Inherently conducting polymer modified polyurethane smart foam for pressure sensing","volume":"119","author":"Brady","year":"2005","journal-title":"Sensors Actuators A Phys."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0780","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0924-4247(99)00392-1","article-title":"Fabrication and test of a thermopneumatic micropump with a corrugated p plus diaphragm","volume":"83","author":"Jeong","year":"2000","journal-title":"Sensors Actuators A Phys."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0785","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0924-4247(96)80088-4","article-title":"A bidirectional silicon micropump","volume":"50","author":"Zengerle","year":"1995","journal-title":"Sensors Actuators A Phys."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0790","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1109\/JMEMS.2003.823215","article-title":"A water-powered micro drug delivery system","volume":"13","author":"Su","year":"2004","journal-title":"J. Microelectromech. Syst."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0795","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.sna.2006.06.014","article-title":"Review of MEMS-based drug delivery and dosing systems","volume":"134","author":"Tsai","year":"2007","journal-title":"Sensors Actuators A Phys."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0800","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1039\/b804690e","article-title":"A refillable microfabricated drug delivery device for treatment of ocular diseases","volume":"8","author":"Lo","year":"2008","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2014.09.030_bb0805","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sna.2007.06.034","article-title":"An electrochemical intraocular drug delivery device","volume":"143","author":"Li","year":"2008","journal-title":"Sensors Actuators A Phys."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0810","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1073\/pnas.78.3.1863","article-title":"Magnetic modulation of release of macromolecules from polymers","volume":"78","author":"Hsieh","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0815","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jbm.820190805","article-title":"Magnetically controlled release systems \u2014 effect of polymer composition","volume":"19","author":"Kost","year":"1985","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0820","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0024-3205(88)90009-4","article-title":"Magnetically responsive microspheres for the pulsed delivery of insulin","volume":"42","author":"Saslawski","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0825","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jbm.820190107","article-title":"Regulation of drug release from polymer matrices by oscillating magnetic-fields","volume":"19","author":"Edelman","year":"1985","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0830","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/jbm.820211202","article-title":"Magnetically enhanced insulin release in diabetic rats","volume":"21","author":"Kost","year":"1987","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2014.09.030_bb0835","first-page":"1","article-title":"Drug delivery technologies and future directions","volume":"25","author":"Verma","year":"2001","journal-title":"Pharm. Technol. On-Line"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:34:24Z","timestamp":1565915664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914006749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":159,"alternative-id":["S0168365914006749"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.09.030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implants for drug delivery to the posterior segment of the eye: A focus on stimuli-responsive and tunable release systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}